Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe safest way to learn Wegovy injection technique is to follow official guidance and, where possible, watch a demonstration video alongside reading the Patient Information Leaflet supplied with your pen. Novo Nordisk and the NHS both provide step-by-step resources; the technique itself is straightforward for most people once the sequence is clear. Wegovy (semaglutide) is a prescription-only medicine, so injection training is part of the clinical support your prescriber provides when treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, demonstrated that participants using semaglutide 2.4mg achieved an average body-weight reduction of around 15% over 68 weeks, but those results depended on consistent, correct use week after week. Adherence to the injection schedule and technique were built into the trial's design. The NHS medicines page for semaglutide reinforces this: the injection should be given on the same day each week, at a consistent time if possible, and rotated across the three approved sites.
Novo Nordisk's official video resources and the Patient Information Leaflet (PIL) supplied inside every Wegovy carton remain the authoritative references for the exact steps. The PIL is the document your prescriber and the manufacturer stand behind; watch any video alongside it rather than instead of it. Our Wegovy overview page explains how semaglutide works and what to expect across the titration schedule.
One thing the evidence is clear on: the subcutaneous route matters. The medicine is designed to be absorbed through the fatty tissue just beneath the skin, not into muscle. Pinching the skin before inserting the needle helps ensure you stay in the right layer, particularly if you are injecting into the thigh or upper arm.
Before you start, wash your hands thoroughly. Remove the pen from the fridge and leave it for around 30 minutes, cold liquid stings more than room-temperature liquid, and a slightly warmer pen makes the process noticeably easier. A question our prescribers hear most weeks is whether the injection has to be given at exactly the same time of day; it does not, but keeping roughly the same day of the week helps with routine and reduces missed doses.
Check the label matches your prescribed dose and look through the viewing window to confirm the liquid is clear and colourless. Do not use the pen if you see particles or if the liquid looks cloudy. Clean the chosen injection site with an alcohol swab and allow it to dry, injecting through wet skin can cause stinging. Medical-grade alcohol swabs are available if you need a fresh supply.
Pinch a fold of skin, hold the pen at a 90-degree angle against it, and press the button firmly. Keep pressure on until you see the yellow indicator in the window and hear the click that signals the dose is complete, then hold for a further six seconds before lifting the pen away. Do not rub the site afterwards. If you are unsure whether the injection completed, do not give a second dose; contact your prescriber or check our guide to Wegovy pen problems.
The three licensed injection sites are the abdomen (at least 5cm from the navel), the front of the thigh, and the outer upper arm. Rotating among these (and moving to a different spot within each site) gives the skin time to recover and reduces the chance of lumps, thickening, or discomfort that can build up with repeated injections in exactly the same place. A simple system is to work around a clockface on each area, or to alternate between sites on a fixed weekly rotation.
Injection-site reactions such as redness, itching, or mild bruising are among the more common side effects noted in clinical data; they are usually short-lived. Persistent lumps under the skin (lipohypertrophy) are worth mentioning to your prescriber, as they can affect absorption if you continue injecting into that area. For a fuller picture of what to watch for during treatment, the NHS semaglutide guidance lists common and uncommon side effects alongside advice on when to seek medical help.
If you want to watch a technique demonstration before your first injection, Wegovy video resources walk through the process visually, and our detailed injection guide covers each stage in writing. Both are worth reviewing together.
Once the injection is done, the pen must go straight into a sharps container, and if you are looking for something sized specifically for this treatment, our Wegovy pen disposal container page covers the options that work well for weekly pen users. Household bins and recycling are not appropriate, used needles pose a risk to anyone handling the waste, and many councils provide free sharps collection for people on regular injections. A 1-litre sharps container is adequate for most patients and keeps disposal simple and compliant.
Missed a dose? The general guidance is to inject as soon as you remember, provided your next scheduled dose is at least two days away. If it is closer than that, skip the missed dose and carry on with your usual day. Always confirm this with your prescriber or refer to the PIL rather than adjusting based on general advice alone, individual circumstances vary. Cost context for ongoing treatment is covered on our Wegovy pricing page. When you are ready to speak with a clinician about starting or continuing treatment, our team is here.
Report any suspected side effects, including unexpected reactions at the injection site, using the MHRA's Yellow Card scheme, patients can submit reports directly, and the data helps keep post-market safety monitoring accurate.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.